Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.23M Sell
22,715
-29
-0.1% -$9.93K 1.92% 17
2026
Q1
$8M Hold
22,744
2.02% 15
2025
Q4
$7.44M Hold
22,744
1.83% 17
2025
Q3
$6.42M Sell
22,744
-18
-0.1% -$5.22K 1.69% 16
2025
Q2
$6.36M Sell
22,762
-10
-0% -$2.83K 1.75% 16
2025
Q1
$7.09M Hold
22,772
2.02% 13
2024
Q4
$5.94M Sell
22,772
-210
-0.9% -$62.3K 1.74% 16
2024
Q3
$7.4M Buy
22,982
+201
+0.9% +$65.7K 2.18% 12
2024
Q2
$7.12M Sell
22,781
-1,667
-7% -$490K 2.25% 12
2024
Q1
$6.95M Sell
24,448
-48
-0.2% -$14K 2.3% 11
2023
Q4
$7.06M Buy
24,496
+28
+0.1% +$7.63K 2.46% 10
2023
Q3
$6.58M Buy
24,468
+559
+2% +$140K 2.5% 10
2023
Q2
$5.31M Buy
23,909
+6
+0% +$1.39K 2.12% 10
2023
Q1
$5.78M Hold
23,903
2.42% 10
2022
Q4
$6.28M Hold
23,903
2.59% 12
2022
Q3
$5.39M Hold
23,903
2.43% 11
2022
Q2
$5.82M Hold
23,903
2.54% 11
2022
Q1
$5.95M Hold
23,903
2.51% 12
2021
Q4
$5.38M Hold
23,903
2.15% 11
2021
Q3
$5.08M Sell
23,903
-121
-0.5% -$27.9K 2.15% 11
2021
Q2
$5.86M Sell
24,024
-22
-0.1% -$5.41K 2.48% 11
2021
Q1
$5.98M Buy
+24,046
New +$5.74M 2.65% 12

Other funds holding AMGN

Navalign LLC's AMGN Position: Q2 2026 in Review

Navalign LLC reduced its Amgen (AMGN) stake by 0.13% in Q2 2026, selling an estimated $9.93K and leaving 22,715 shares worth $8.23M. The position accounts for 1.92% of the portfolio, ranked #17.

Navalign LLC first reported a position in AMGN in Q1 2021 and has held it in 22 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Navalign LLC held 22,715 shares of Amgen worth $8.23M as of Q2 2026.
  • Navalign LLC sold 29 Amgen shares in Q2 2026, an estimated $9.93K.
  • Amgen made up 1.92% of Navalign LLC's portfolio in Q2 2026, its #17 holding.
  • Navalign LLC first reported a position in Amgen in Q1 2021 and has held it in 22 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.